As reported in the Journal of Oncology Practice by Regnante et al, the National Minority Quality Forum and Sustainable Healthy Communities Diverse Cancer Communities Working Group identified strategies employed by U.S. Cancer Centers of Excellence that have resulted in increased inclusion of racial and ethnic minority groups in clinical trials.
The Communities Working Group identified U.S. cancer centers with increased success in enrolling racial and ethnic minority groups in cancer clinical trials on the basis of the following criteria:
Leaders of such cancer centers were interviewed in depth to identify practices that facilitate racial and ethnic minority group accrual in clinical trials.
Notable strategies were identified across five broad themes:
Particular key practices included:
The investigators concluded, “We have identified notable practices that facilitate increased participation of racial and ethnic minority groups in cancer trials. Wide implementation of such strategies across cancer centers is essential to ensure that all populations benefit from advances in an era of increasingly personalized treatment of cancer.”
Jeanne M. Regnante, of Sustainable Healthy Communities, LLC, is the corresponding author for the Journal of Oncology Practice article.
Disclosure: The study authors' full disclosures can be found at jop.ascopubs.org.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.